Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes
The pathogenic drivers of sporadic and familial motor neuron disease (MND), such amyotrophic lateral sclerosis (ALS), are unknown. MND impairs the Ran GTPase cycle, which controls nucleocytoplasmic transport, ribostasis and proteostasis; however, cause-effect mechanisms of Ran GTPase modulators in m...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2017-05-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/10/5/559 |
_version_ | 1818153185960787968 |
---|---|
author | Kyoung-in Cho Dosuk Yoon Sunny Qiu Zachary Danziger Warren M. Grill William C. Wetsel Paulo A. Ferreira |
author_facet | Kyoung-in Cho Dosuk Yoon Sunny Qiu Zachary Danziger Warren M. Grill William C. Wetsel Paulo A. Ferreira |
author_sort | Kyoung-in Cho |
collection | DOAJ |
description | The pathogenic drivers of sporadic and familial motor neuron disease (MND), such amyotrophic lateral sclerosis (ALS), are unknown. MND impairs the Ran GTPase cycle, which controls nucleocytoplasmic transport, ribostasis and proteostasis; however, cause-effect mechanisms of Ran GTPase modulators in motoneuron pathobiology have remained elusive. The cytosolic and peripheral nucleoporin Ranbp2 is a crucial regulator of the Ran GTPase cycle and of the proteostasis of neurological disease-prone substrates, but the roles of Ranbp2 in motoneuron biology and disease remain unknown. This study shows that conditional ablation of Ranbp2 in mouse Thy1 motoneurons causes ALS syndromes with hypoactivity followed by hindlimb paralysis, respiratory distress and, ultimately, death. These phenotypes are accompanied by: a decline in the nerve conduction velocity, free fatty acids and phophatidylcholine of the sciatic nerve; a reduction in the g-ratios of sciatic and phrenic nerves; and hypertrophy of motoneurons. Furthermore, Ranbp2 loss disrupts the nucleocytoplasmic partitioning of the import and export nuclear receptors importin β and exportin 1, respectively, Ran GTPase and histone deacetylase 4. Whole-transcriptome, proteomic and cellular analyses uncovered that the chemokine receptor Cxcr4, its antagonizing ligands Cxcl12 and Cxcl14, and effector, latent and activated Stat3 all undergo early autocrine and proteostatic deregulation, and intracellular sequestration and aggregation as a result of Ranbp2 loss in motoneurons. These effects were accompanied by paracrine and autocrine neuroglial deregulation of hnRNPH3 proteostasis in sciatic nerve and motoneurons, respectively, and post-transcriptional downregulation of metalloproteinase 28 in the sciatic nerve. Mechanistically, our results demonstrate that Ranbp2 controls nucleocytoplasmic, chemokine and metalloproteinase 28 signaling, and proteostasis of substrates that are crucial to motoneuronal homeostasis and whose impairments by loss of Ranbp2 drive ALS-like syndromes. |
first_indexed | 2024-12-11T14:06:36Z |
format | Article |
id | doaj.art-870d58a5967b4d6ea8eef324fdf4e1d6 |
institution | Directory Open Access Journal |
issn | 1754-8403 1754-8411 |
language | English |
last_indexed | 2024-12-11T14:06:36Z |
publishDate | 2017-05-01 |
publisher | The Company of Biologists |
record_format | Article |
series | Disease Models & Mechanisms |
spelling | doaj.art-870d58a5967b4d6ea8eef324fdf4e1d62022-12-22T01:03:38ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112017-05-0110555957910.1242/dmm.027730027730Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromesKyoung-in Cho0Dosuk Yoon1Sunny Qiu2Zachary Danziger3Warren M. Grill4William C. Wetsel5Paulo A. Ferreira6 Department of Ophthalmology, Duke University Medical Center, Durham, NC 27710, USA Department of Ophthalmology, Duke University Medical Center, Durham, NC 27710, USA Department of Ophthalmology, Duke University Medical Center, Durham, NC 27710, USA Department of Biomedical Engineering, Duke University, Durham, NC 27710, USA Department of Biomedical Engineering, Duke University, Durham, NC 27710, USA Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical Center, Durham, NC 27710, USA Department of Ophthalmology, Duke University Medical Center, Durham, NC 27710, USA The pathogenic drivers of sporadic and familial motor neuron disease (MND), such amyotrophic lateral sclerosis (ALS), are unknown. MND impairs the Ran GTPase cycle, which controls nucleocytoplasmic transport, ribostasis and proteostasis; however, cause-effect mechanisms of Ran GTPase modulators in motoneuron pathobiology have remained elusive. The cytosolic and peripheral nucleoporin Ranbp2 is a crucial regulator of the Ran GTPase cycle and of the proteostasis of neurological disease-prone substrates, but the roles of Ranbp2 in motoneuron biology and disease remain unknown. This study shows that conditional ablation of Ranbp2 in mouse Thy1 motoneurons causes ALS syndromes with hypoactivity followed by hindlimb paralysis, respiratory distress and, ultimately, death. These phenotypes are accompanied by: a decline in the nerve conduction velocity, free fatty acids and phophatidylcholine of the sciatic nerve; a reduction in the g-ratios of sciatic and phrenic nerves; and hypertrophy of motoneurons. Furthermore, Ranbp2 loss disrupts the nucleocytoplasmic partitioning of the import and export nuclear receptors importin β and exportin 1, respectively, Ran GTPase and histone deacetylase 4. Whole-transcriptome, proteomic and cellular analyses uncovered that the chemokine receptor Cxcr4, its antagonizing ligands Cxcl12 and Cxcl14, and effector, latent and activated Stat3 all undergo early autocrine and proteostatic deregulation, and intracellular sequestration and aggregation as a result of Ranbp2 loss in motoneurons. These effects were accompanied by paracrine and autocrine neuroglial deregulation of hnRNPH3 proteostasis in sciatic nerve and motoneurons, respectively, and post-transcriptional downregulation of metalloproteinase 28 in the sciatic nerve. Mechanistically, our results demonstrate that Ranbp2 controls nucleocytoplasmic, chemokine and metalloproteinase 28 signaling, and proteostasis of substrates that are crucial to motoneuronal homeostasis and whose impairments by loss of Ranbp2 drive ALS-like syndromes.http://dmm.biologists.org/content/10/5/559Ran-binding protein 2Chemokine signalingTranscriptomicsProteostasisMotoneuronMouse gene knock-outNucleocytoplasmic transportMetalloproteinaseAmyotrophic lateral sclerosis |
spellingShingle | Kyoung-in Cho Dosuk Yoon Sunny Qiu Zachary Danziger Warren M. Grill William C. Wetsel Paulo A. Ferreira Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes Disease Models & Mechanisms Ran-binding protein 2 Chemokine signaling Transcriptomics Proteostasis Motoneuron Mouse gene knock-out Nucleocytoplasmic transport Metalloproteinase Amyotrophic lateral sclerosis |
title | Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes |
title_full | Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes |
title_fullStr | Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes |
title_full_unstemmed | Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes |
title_short | Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes |
title_sort | loss of ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling proteostasis of hnrnph3 and mmp28 and development of amyotrophic lateral sclerosis like syndromes |
topic | Ran-binding protein 2 Chemokine signaling Transcriptomics Proteostasis Motoneuron Mouse gene knock-out Nucleocytoplasmic transport Metalloproteinase Amyotrophic lateral sclerosis |
url | http://dmm.biologists.org/content/10/5/559 |
work_keys_str_mv | AT kyoungincho lossofranbp2inmotoneuronscausesdisruptionofnucleocytoplasmicandchemokinesignalingproteostasisofhnrnph3andmmp28anddevelopmentofamyotrophiclateralsclerosislikesyndromes AT dosukyoon lossofranbp2inmotoneuronscausesdisruptionofnucleocytoplasmicandchemokinesignalingproteostasisofhnrnph3andmmp28anddevelopmentofamyotrophiclateralsclerosislikesyndromes AT sunnyqiu lossofranbp2inmotoneuronscausesdisruptionofnucleocytoplasmicandchemokinesignalingproteostasisofhnrnph3andmmp28anddevelopmentofamyotrophiclateralsclerosislikesyndromes AT zacharydanziger lossofranbp2inmotoneuronscausesdisruptionofnucleocytoplasmicandchemokinesignalingproteostasisofhnrnph3andmmp28anddevelopmentofamyotrophiclateralsclerosislikesyndromes AT warrenmgrill lossofranbp2inmotoneuronscausesdisruptionofnucleocytoplasmicandchemokinesignalingproteostasisofhnrnph3andmmp28anddevelopmentofamyotrophiclateralsclerosislikesyndromes AT williamcwetsel lossofranbp2inmotoneuronscausesdisruptionofnucleocytoplasmicandchemokinesignalingproteostasisofhnrnph3andmmp28anddevelopmentofamyotrophiclateralsclerosislikesyndromes AT pauloaferreira lossofranbp2inmotoneuronscausesdisruptionofnucleocytoplasmicandchemokinesignalingproteostasisofhnrnph3andmmp28anddevelopmentofamyotrophiclateralsclerosislikesyndromes |